Inventor
Andrew TUSTIAN
Inventor
US
Overview
Patents· 17 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides17%
G01NInvestigating or analysing materials by determining their chemical or physical properties17%
A61KPreparations for medical, dental or toiletry purposes13%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%
C12NMicroorganisms or enzymes13%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture13%
C12YEnzymes13%
B01DSeparation2%
PatentTitleYear
12,545,702Methods for removing undesired components during multistage chromatographic processes202612,398,176Use of Raman spectroscopy in downstream purification202512,202,883Anti-VEGF protein compositions and methods for producing the same202512,152,056Method and chromatography system for determining amount and purity of a multimeric protein202412,077,570Anti-VEGF protein compositions and methods for producing the same202412,054,533Anti-VEGF protein compositions and methods for producing the same202412,049,489Anti-VEGF protein compositions and methods for producing the same202411,649,273Anti-VEGF protein compositions and methods for producing the same202311,505,594Anti-VEGF protein compositions and methods for producing the same202211,459,374Anti-VEGF protein compositions and methods for producing the same202211,459,373Anti-VEGF protein compositions and methods for producing the same202211,407,813Anti-VEGF protein compositions and methods for producing the same202211,358,984Use of Raman spectroscopy in downstream purification202211,299,532Anti-VEGF protein compositions and methods for producing the same202211,286,290Anti-VEGF protein compositions and methods for producing the same202211,180,540Anti-VEGF protein compositions and methods for producing the same202111,174,283Anti-VEGF protein compositions and methods for producing the same2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to REGENERON PHARMA (17)· patent assignee history
2021–2022Patents assigned to REGENERAN PHARMACEUTICALS INC (3)· patent assignee history
2021–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 17 | 2021–2026 |
| REGENERAN PHARMACEUTICALS INC | 3 | 2021–2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 17 | 2021–2026 |